Anson Funds Management’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Anson Funds Management’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,124,541	Closed	-$1.46M	–	59
2018 Q3	$1.46M	Buy	+1,124,541	New	+$558K	0.52%	10

Other funds holding PAVMZ

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

MRCM

M&R Capital Management Summit, New Jersey $454M AUM 40.11% 1-Year Est. Return

LWAC

Laurel Wealth Advisors (California) Solana Beach, California $1.01B AUM 13.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Anson Funds Management's PAVMZ Position: Q4 2018 in Review

Anson Funds Management sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q4 2018, closing a stake of 1,124,541 shares — an estimated $1.46M sold.

Anson Funds Management first reported a position in PAVMZ in Q3 2018 and held it in 1 quarter. The position peaked at $1.46M in Q3 2018. 7 funds tracked by Wall St. Rank hold PAVMZ as of Q4 2018.

Anson Funds Management reported no remaining PAVmed Inc. Series Z Warrant position as of Q4 2018 after selling out during the quarter.
Anson Funds Management sold 1,124,541 PAVmed Inc. Series Z Warrant shares in Q4 2018, an estimated $1.46M.
Anson Funds Management first reported a position in PAVmed Inc. Series Z Warrant in Q3 2018 and held it in 1 quarter.
Anson Funds Management's PAVmed Inc. Series Z Warrant position peaked at $1.46M in Q3 2018.
7 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q4 2018.

Based on Anson Funds Management's 13F filing for Q4 2018, filed 14 Feb 2019.